Healthcare IT Consultant with 30 years experience in vendor, provider and
consulting sector to streamline healthcare IT standards development
ATLANTA, Sept. 18 /PRNewswire/ -- Health Level Seven (HL7), a preeminent healthcare IT standards development organization with broad international representation, today announced the appointment of John Quinn as Chief Technology Officer (CTO). Accenture and HL7 have reached an agreement in principle and Quinn, who is CTO of Accenture's US Provider Practice, will immediately assume the responsibilities of CTO of HL7. A final agreement with Accenture will be signed within the next few weeks.
In his role as HL7 CTO, Quinn will implement HL7's product and services strategy in conjunction with the CEO, oversee the timely delivery of standards, and report on progress of key initiatives and specifications to the membership and stakeholders. He will lead HL7's Technical Steering Committee, support the harmonization of standards with other standard development organizations, oversee the work of staff project managers and ensure the quality of ballots and specifications.
"We are pleased to have John join the executive team of HL7," said Charles Jaffe, MD, PhD, and CEO of HL7. "John has 20 years experience supporting HL7 initiatives as a founder and volunteer. He has earned the deep respect of the healthcare IT community around the world."
Hiring a CEO and a CTO were strategic recommendations made by the healthcare community as part of a 2005 Robert Wood Johnson Foundation grant to address the organization's long-term objectives and support the organization to more efficiently and expeditiously develop standards while maintaining the organization's essential characteristics. Charles Jaffe, MD, PhD, joined HL7 as CEO in February 2007.
"I look forward to working with the membership and technical committees to enhance the product and services of HL7," said John Quinn. "The addition of this position to the HL7 executive team will enable the organization to develop, coordinate and harmonize HL7's technical architecture to meet the needs of the healthcare industry."
This month HL7 restructured its Technical Steering Committee into a streamlined group of up to ten members who will focus on delivering the organization's product and services strategy. The HL7 Technical Steering Committee oversees and coordinates the technical effort contributed by the HL7 volunteers who make up the HL7 Working Group. Its mission is to assure that the efforts of the Working Group are focused on the overall HL7 mission established by the Board. Both the new Technical Services Committee and the CTO will oversee the direction and speed of the development of HL7's healthcare IT standards development.
Currently the CTO of Accenture's US Provider Practice, Quinn will continue to be an employee of Accenture during his tenure at HL7. Accenture will financially support Quinn's position as CTO of HL7. Accenture is currently a Benefactor supporter of HL7.
Quinn has worked with Accenture's team of architects developing Accenture's solutions to national electronic healthcare integration in the US, Canada and UK. He was a contributing architect to Accenture's ONCHIT project for a prototype NHIN and three associated RHIOs. In addition, he has worked on many international Accenture projects.
As an HL7 Board member since 1987, Quinn's volunteer experience includes acting as the organization's second Board chair, and since 1990 he has served as the Technical Steering Committee Chair.
Quinn has advanced degrees in electrical engineering from Loyola University in Los Angeles, where he taught Computer Science for 20 years.
Founded in 1987, Health Level Seven, Inc. (http://www.HL7.org) is a not-for-profit, ANSI-accredited standards developing organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7's more than 2,300 members represent approximately 500 corporate members, which includes more than 90 percent of the information systems vendors serving healthcare.
HL7's endeavors are sponsored, in part, by the support of its benefactors: Accenture; Booz Allen Hamilton, Boston Scientific Corporation, Centers for Disease Control and Prevention; Duke Clinical Research Institute (DCRI); Eclipsys Corporation; Eli Lilly & Company; Epic Systems Corporation; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; McKesson Provider Technologies; Microsoft Corporation; Misys Healthcare Systems; NHS Connecting for Health; NICTIZ National Healthcare; Novartis; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Medical Systems; Progress Software Corporation-DataDirect Technologies Division; QuadraMed Corporation; Quest Diagnostics Inc.; Science Applications International Corporation; Siemens Medical Solutions Health Services; Solucient, LLC.; St. Jude Medical; the U.S. Department of Defense, Military Health System; the U.S. Department of Veterans Affairs; and Wyeth Pharmaceuticals.
Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Austria, Brazil, Canada, China, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Korea, Mexico, The Netherlands, New Zealand, Romania, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, and Uruguay.
|SOURCE Health Level Seven, Inc.|
Copyright©2007 PR Newswire.
All rights reserved